NIH Director Addresses Gain-of-Function Research Funding with Senator Tuberville
Forbes Breaking NewsFebruary 4, 20263 min1,200 views
9 connectionsΒ·10 entities in this videoβNIH Transparency and Public Trust
- π‘ NIH is working to increase transparency by removing temporary delays in accessing federally funded research, allowing taxpayers to see results sooner.
- β This initiative aims to rebuild trust among Americans who feel science has become politicized.
Fetal Tissue Research Policy
- π¬ NIH has ended the use of human fetal tissue from elective abortions in all taxpayer-funded research.
- β οΈ This decision was made because better alternatives are available that are not ethically conflicted, and to ensure NIH research is morally acceptable to the public.
Funding Disparities
- π A significant disparity exists between funding for osteopathic medicine schools (0.1%) and MD granting schools (40%) from NIH.
- π― The NIH portfolio is considered too concentrated in a few institutions, with plans to broaden the base of funding to include a larger range of ideas and places.
Gain-of-Function Research Funding
- β Senator Tuberville questioned the NIH Director about whether gain-of-function research is being funded domestically and worldwide.
- π« The NIH Director stated that the US will not fund any dangerous gain-of-function research, including future programs in Wuhan, China.
Knowledge graph10 entities Β· 9 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
10 entities
Chapters1 moments
Key Moments
Transcript13 segments
Full Transcript
Topics11 themes
Whatβs Discussed
Gain-of-Function ResearchNIHSenator Tommy TubervilleJay BhattacharyaTaxpayer-funded researchHuman fetal tissueOsteopathic medicineMD granting schoolsWuhan, ChinaTransparencyPublic trust
Smart Objects10 Β· 9 links
CompanyΒ· 1
ConceptsΒ· 8
LocationΒ· 1